Graham Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
HRCM
GS
OAM
Graham Capital Management's CDNA Position: Q2 2025 in Review
Graham Capital Management sold out of CareDx (CDNA) in Q2 2025, closing a stake of 25,368 shares — an estimated $450K sold.
Graham Capital Management first reported a position in CDNA in Q3 2022 and held it in 4 quarters. The position peaked at $898K in Q3 2022. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.
- Graham Capital Management reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
- Graham Capital Management sold 25,368 CareDx shares in Q2 2025, an estimated $450K.
- Graham Capital Management first reported a position in CareDx in Q3 2022 and held it in 4 quarters.
- Graham Capital Management's CareDx position peaked at $898K in Q3 2022.
- 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.
Based on Graham Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.